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The R2TP complex is a HSP90 co-chaperone, which consists of four subunits: PIH1D1,
RPAP3, RUVBL1, and RUVBL2. It is involved in the assembly of large protein or protein–
RNA complexes such as RNA polymerase, small nucleolar ribonucleoproteins (snoRNPs),
phosphatidylinositol 3 kinase-related kinases (PIKKs), and their complexes. While RPAP3
has a HSP90 binding domain and the RUVBLs comprise ATPase activities important for
R2TP functions, PIH1D1 contains a PIH-N domain that speciﬁcally recognizes phospho-
rylated substrates of the R2TP complex. In this review we provide an overview of the
current knowledge of the R2TP complex with the focus on the recently identiﬁed structural
and mechanistic features of the R2TP complex functions. We also discuss the way R2TP
regulates cellular response to stress caused by low levels of nutrients or by DNA damage
and its possible exploitation as a target for anti-cancer therapy.
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HSP90 AND ITS CO-CHAPERONES
Chaperones are proteins involved in protein folding and protein-
complex assembly or disassembly (Macario and Conway de
Macario, 2005). Heat shock protein 90 (HSP90) is an abun-
dantly expressed chaperone implicated in a wide range of cellular
processes, including cell signaling, protein degradation, genome
maintenance and assembly of transcriptional and translational
machineries (Prodromou et al., 1997; Li et al., 2012; Saibil, 2013).
HSP90 client proteins are often in near-native state and HSP90
is involved in the late stages of their folding (Jakob et al., 1995).
HSP90 acts as a dimer and its substrate speciﬁcity and activity
are given by its co-chaperones (Ali et al., 2006; Li et al., 2012).
Althoughmost of the well-knownHSP90 co-chaperones are small
single-molecule proteins (CDC37, p23, SGT1, AHA1), recent
work has shown that HSP90 co-chaperones can be multi-protein
complexes themselves, such as the R2TP complex (Zhao et al.,
2005; Li et al., 2012).
R2TP COMPLEX
The R2TP complex was discovered in budding yeasts as an Hsp90-
interacting protein-complex (Zhao et al., 2005). It is involved in
the assembly of large number of multi-subunit complexes: (a) the
small nucleolar ribonucleoproteins (snoRNPs),which are essential
for biogenesis of ribosomes, spliceosomes, and tRNAs (Zhao et al.,
2008; McKeegan et al., 2009); (b) RNA polymerase II (Boulon
et al., 2010) and (c) phosphatidylinositol 3-kinase-related kinases
(PIKKs) and their complexes (Horejsi et al., 2010) that are involved
in DNA damage signaling (ATM, ATR, DNA-PKcs), transcription
regulation (TRRAP), nonsense mediated mRNA decay (SMG1),
and nutrient signaling (mTOR; Izumi et al., 2012; Figure 1).
Although the R2TP complex has become recently focus of many
studies, the exact function and the molecular mechanism of its
action is still not clear.
COMPONENTS OF THE R2TP COMPLEX
The R2TP complex is highly conserved from yeast to mammals
and consists of four subunits: PIH1D1, RPAP3, RUVBL1 and
RUVBL2, known under diverse names (Table 1; Zhao et al., 2005).
The complex also associates with prefoldin and prefoldin-like pro-
teins PFDN2, PFDN6, UXT, WDR92, URI and PDRG1, which
form so called prefoldin-like complex, also implied in protein-
complex assembly (Cloutier et al., 2009; Cloutier and Coulombe,
2010; Figure 2).
RUVBL1 and RUVBL2 belong to AAA+ ATPases family
(ATPases associated with a variety of cellular activities) and are
essential for viability in all so far examinedmodel organisms (Sac-
charomyces cerevisiae, Drosophila melanogaster, and Caenorhab-
ditis elegans; Nano and Houry, 2013). The AAA+ ATPases are
characterized by presence of an AAA+ domain containingWalker
A and B motifs, sensor domains 1 and 2 and an arginine ﬁnger
(Patel and Latterich, 1998; Neuwald et al., 1999; Jha and Dutta,
2009). The Walker A motif binds ATP while the Walker B motif
is involved in ATP hydrolysis, providing together ATPase activ-
ity. The sensor domains detect whether the ATPase is bound to
ATP or ADP and the arginine ﬁnger either affects ATP hydrolysis
or converts ATP hydrolysis into a mechanical output (Guenther
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FIGURE 1 | (Potential) functions of the R2TP complex. Known functions of
the R2TP complex are indicated in blue, potential R2TP functions are
indicated in red. SMG1 complex and mTOR stabilization by the R2TP complex
requires binding of PIH1D1 with the PIH-N domain to TEL2. Other potential
PIH-N domain binding proteins are indicated, but their role for R2TP complex
function remains to be studied.
et al., 1997; Ogura et al., 2004). Although in vitro data show no
or limited ATPase activity of RUVBL1 and RUVBL2 (Grigoletto
et al., 2011), some in vivo functions are impaired after mutation
of the Walker A or B motifs: for example mutations of the
yeast proteins comprising the ATPase activity result in serious
growth defects while inactivation of the mammalian RUVBL1/2
activity decreases activation of mTOR and stability of the telom-
erase component TERC (Jonsson et al., 2004; Venteicher et al.,
2008; Kim et al., 2013). It is therefore highly probable that the
ATPase activity of RUVBL1/2 is important for at least part of
their functions and that they might need other proteins, absent
in the in vitro assays, that promote the ATPase activity. The puri-
ﬁed proteins also exhibit a weak helicase activity (Huen et al.,
2010).
The crystal structures of RUVBL1 revealed three structural sub-
domains –N terminal andC terminal subdomains form theAAA+
domain, while a ﬂexible middle domain (also called the inser-
tion domain), is involved in DNA or RNA binding. The insertion
domain is located outside the core of the protein and is speciﬁc
for RUVBL1/2 but not for other members of the AAA+ ATPases
family and its deletion in both RUVBL1/2 increased their ATPase
and helicase activity, indicating an auto-inhibitory function of this
domain (Matias et al., 2006; Niewiarowski et al., 2010; Petukhov
et al., 2012).
AAA+ ATPases often constitute hexamers (Smith et al., 2006)
and accordingly, RUVBL1 and RUVBL2 form homo or hetero
hexamers and/or double-hexameric structures – dodecamers. The
crystal structure of a RUVBL1monohexamer reveals a strongADP
binding by the AAA+ domain, which could explain its very low
ATPase activity and indicating that the monohexamer is possibly
not physiologically relevant (Matias et al., 2006). Yeast Rvb1 and
Rvb2 incubated together form a hexameric ring, observed by elec-
tron microscopy and scanning transmission electron microscopy.
Together the proteins have higher ATPase and helicase activity
compared with the separate proteins (Gribun et al., 2008). Many
studies also show formation of a dodecamer, consisting of both
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Table 1 | Alternative names for the components of the R2TP complex.
Mammals Yeast
PIH1D1 NOP17 Nop17, Pih1
RPAP3 hSPAGH Tah1
RUVBL1 Pontin, RVB1, TIP49A, TAP54α,
ECP-54, TIH1, p50
Rvb1
RUVBL2 Reptin, RVB2,TIP49B,TAP54β,
ECP-51, TIH2, p47
Rvb2
RUVBL1 and RUVBL2 (Puri et al., 2007; Torreira et al., 2008;
Niewiarowski et al., 2010; Gorynia et al., 2011). Antibody label-
ing of Rvb2 in the yeast complex revealed that only one of the
two rings contained this protein, arguing for two monomeric
hexameres (Torreira et al., 2008). The crystal structure and mass
spectrometry analysis of the human RUBVL1/2 complex supports
formation of a dodecamer composed from two heterogenic hex-
ameres (Niewiarowski et al., 2010; Gorynia et al., 2011). In the
dodecameric complex, ATPase activity of both proteins is required
to catalyze the ATP reaction (Puri et al., 2007) and depending
on the arrangement of the insertion domain, the RUVBL com-
plex forms a compact or a stretched conﬁrmation (Lopez-Perrote
et al., 2012). Interestingly, apart from a 3:3 ratio of RUVBL1/2,
hexameres with different stoichiometry of RUVBL1/2 were also
detected (Niewiarowski et al., 2010). The different conformations
could represent the diverse range of functions these proteins play
in vivo: one conformation could be important for helicase activity,
while another one may be involved in protein-complex assembly
(Torreira et al., 2008). Moreover, the independent and some-
times even opposing effects of RUVBL1/2 on transcription suggest
that the ATPases can act independently on each other (Gallant,
2007).
RUVBL1 and RUVBL2 take part in many cellular processes:
they are components of chromatin remodeling complexes TIP60,
SWR/SRCAP, and INO80 and very recently they have been
reported to interact with the Fanconi anemia core complex, which
is involved inDNA inter-strand crosslink repair (Rosenbaumet al.,
2013; Rajendra et al., 2014). RUVBL1/2 also inﬂuence transcrip-
tion, play a role in assembly of the mitotic spindle and telomerase
complex and (as a part of the R2TP complex) are involved in RNA
polymerase II assembly, PIKK complex formation and snoRNPs
biogenesis (Nano and Houry, 2013). The exact role of RUVBL1
and RUVBL2 in these processes remains to be determined. Pub-
lished data suggest that their main function may be assembly or
activation of the complexes in which they are contained. This
theory supports the fact, that the protein level of Rvb1 and
Rvb2 in yeasts is low compared to the abundance of the com-
plexes in which they are involved and therefore only associate
with these complexes transiently (Gallant, 2007; Nano and Houry,
2013).
RPAP3 and PIH1D1 are subunits speciﬁc exclusively for the
R2TP complex. The yeast RPAP3 homolog Tah1 interacts with
Pih1 via its C-terminal part and contains one tetratricopeptide
FIGURE 2 | HSP90-R2TP complex in yeast and mammals. Proteins
homologous between Yeast and mammals are shown in the same color.
N indicates the N-terminal domain, C the C-terminal domain and M the
middle domain of a protein. Yeast Tah1 contains one TPR domain and
therefore two Tah1 molecules are needed to bind the Hsp90 dimer. Tah1
binds Pih1, which in turn binds R2TP target substrates with its N-terminal
domain and the Rvbl proteins with its middle domain. In contrast the
mammalian R2TP complex binds the HSP90 dimer with one RPAP3
molecule containing two TPR domains. The RPAP3 C-terminal domain
connects directly or indirectly with the other components of the complex,
namely PIH1D1 the RUVBLs and the prefoldin-like complex components
(absent in yeast R2TP).
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(TPR) domain (Zhao et al., 2005; Millson et al., 2008). TPR
domains are known to facilitate interactions with HSP70 or
HSP90 and are implicated in other protein–protein interactions
(Smith, 2004). The Tah1 TPR domain is involved in binding
of Hsp90 but not of Hsp70 in stressed stationary cells and is
not essential for Hsp90 recruitment to the R2TP complex (Mill-
son et al., 2008; Zhao et al., 2008). While mutation of the Tah1
TPR domain decreased Tah1-Hsp90 interaction, it did not affect
Tah1-Pih1 interaction. Tah1 forms a dimer, which binds both
Hsp90 proteins present in the Hsp90 dimer, preventing its simul-
taneous binding to other co-chaperones (Pal et al., 2014). The
drosophila RPAP3 homolog Spagh contains one TPR domain
that binds both Hsp70 and Hsp90 and stimulates their activ-
ities (Benbahouche Nel et al., 2014). The presence of two TPR
domains in human RPAP3 and its strong interaction with HSP90
and HSP70 indicate that RPAP3 couples the R2TP complex
with HSP90 and possibly with other chaperones (Smith, 2004;
Chagot et al., 2014). Crystallographic analysis of RPAP3 shows
an interaction between both TPR domains and HSP90 peptides
containing the conserved MEEVD sequence. Abolishing HSP90
binding requires mutation of both TPR domains, suggesting that
the HSP90 dimer is bound by one RPAP3 molecule (Pal et al.,
2014). RPAP3 is expressed in three isoforms: isoform 1 (and
possibly isoform 3) interacts with PIH1D1 and is required for
its stabilization, isoform 2 lacks an in-frame exon coding for 34
amino acids, present in the other two isoforms, and does not
interact with PIH1D1, and therefore it may antagonize the R2TP
complex activity. The C-terminal part of RPAP3 binds (inde-
pendently on the TPR domains) a subunit of the prefoldin-like
complex WDR92 and thus may mediate the interaction between
R2TP and prefoldin-like complex (Itsuki et al., 2008; Back et al.,
2013).
In yeast, Pih1 plays a central role in the R2TP complex by
directly binding the other complex components (Kakihara and
Houry, 2012). It has been proposed that Hsp90 and Tah1 stabi-
lize the otherwise unstable Pih1 (Paci et al., 2012). Similarly to
Tah1, Pih1 has Hsp90 binding properties, although the interac-
tion is relatively weak, and the C-terminal domain of Pih1 binds
the C-terminal domain of Tah1 (Zhao et al., 2008; Eckert et al.,
2010; Paci et al., 2012; Back et al., 2013; Pal et al., 2014). In addi-
tion, Pih1 interacts with Rvb1 and Rvb2 by its middle domain. In
mammals, RPAP3 andHSP90 also act together to stabilize PIH1D1
and PIH1D1 possibly connects the components of the R2TP com-
plex (Zhao et al., 2008; Paci et al., 2012).While the middle domain
is not present in mammalian PIH1D1, the C-terminal part rang-
ing from amino acid 250 to 290 mediates the interaction with the
rest of the R2TP complex, although it is not clear which of the
R2TP complex components binds to the C-terminal part directly
(Horejsi et al., 2014).
Two recently published papers identiﬁed a novel PIH1D1
phospho-peptide binding domain (PIH-N domain), distinct from
any so far known phospho-binding-domains. The domain is capa-
ble of binding PIH1D1 interaction partner TEL2 independently
of the rest of the complex. The PIH-N domain structures of the
mouse and the human proteins are very similar. Both studies iden-
tiﬁed a basic patch within the N-terminal domain of PIH1D1,
which is responsible for binding to TEL2 peptide containing a
phosphorylated acidic DpSDD sequence. The crystal structure
of the human PIH1D1 revealed hydrogen bonds essential for
the binding between lysine 57, lysine 64, and arginine 168 of
PIH1D1 (lysine 57, 64, and 133 in mouse) and the phosphory-
lated serine and aspartates of the DpSDD motif. Mutations of
these PIH1D1 residues abolished TEL2 peptide binding (Horejsi
et al., 2014; Pal et al., 2014). Lysine 57 and lysine 64 are evo-
lutionary conserved and accordingly, mutation of lysine 64 in
PIH1D1 abolished interaction with TEL2. Mass spectrometry
and pull-down experiments revealed that PIH-N domain inter-
acts directly in a phosphorylation-dependent manner with novel
PIH1D1 interacting partners ECD, SNRP116, and UBR5. The
mass spectrometry results also suggest that interaction between
PIH1D1 and the main subunit of RNA polymerase II RPB1 is
phosphorylation-dependent and that lysine 64 is essential for
the interaction. Nevertheless, it is not clear whether the inter-
action with RPB1 is direct or mediated by another factor (Horejsi
et al., 2014). These data indicate that PIH-N domain recognizes
and recruits speciﬁc substrates to the R2TP during assembly of
PIKKs, snoRNPs and RNA polymerase II and possibly of other
complexes.
A phospho-binding domain similar to the PIH-N is probably
also present in PIH1D1 ortholog Kintoun, which is involved in
the cytoplasmatic assembly of dyneins, required for cilia motility
(Omran et al., 2008). The positively charged lysines important
for the PIH-N binding are substituted with positively charged
arginines in Kintoun and it is capable of binding the phospho-
rylated TEL2 peptide with weak afﬁnity (Horejsi et al., 2014; Pal
et al.,2014). SinceKintoun interactswithDYX1C1, aTPRdomain-
containing protein involved in dynein assembly, it could function
as a co-chaperone in a similar way as PIH1D1 in the R2TP complex
(Tarkar et al., 2013).
ASSEMBLY OF snoRNPs
SnoRNPs are RNA-protein complexes essential for biogenesis of
ribosomes, spliceosomes, and telomerase (Smith and Steitz, 1997).
The two major groups of snoRNPs are the box C/D snoRNPs
(involved in processing of the pre-rRNAby 2′-O-methylation) and
the H/ACA snoRNPs (involved in pseudouridylation of the pre-
rRNA; Kiss-Laszlo et al., 1996; Tycowski et al., 1996). Assembly of
snoRNPs is a complicated process, which requires a number of
assembly factors.
The box C/D snoRNPs consist of box C/D snoRNAs and four
core protiens: Snu13, Nop1, Nop56, and Nop58. Tah1 deple-
tion in yeast led to decreased stability of box C/D snoRNAs and
this effect was apparent only in stressed cells in stationary phase,
possibly because Tah1 and Hsp90 are required for Pih1 stabiliza-
tion under these conditions (Zhao et al., 2008). Rvb2 and Pih1
depletion led to a temperature sensitive phenotype and a distur-
bance in the accumulation and localization of both box C/D and
H/ACA snoRNPs (Newman et al., 2000; Boulon et al., 2008). A
synthetic genetic array, a method that identiﬁes genes involved
in the same pathway or complex, implicated genetic interactions
of both Pih1 and Rvbs with Nop58p (Zhao et al., 2008). Pih1
directly binds the box C/D core protein Nop58 via Nop58 C-
terminus (Gonzales et al., 2005; Kakihara et al., 2014) and the
interaction is stronger in the absence of RNA. Binding of ADP,
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ATP, and ATPgS by Rvb1/2 (but not ATP hydrolysis) leads to
dissociation of the R2TP complex itself and also releases R2TP
from Nop58 C-terminal domain. Since the Walker A and Walker
B motifs of Rvb1/2 are essential for yeast C/D snoRNA accumu-
lation, the ATPase activity must play a role at a different step of
the snoRNPs assembly (King et al., 2001; McKeegan et al., 2007,
2009; Boulon et al., 2008). Given that the R2TP complex interacts
with the earliest stage of the snoRNP complex, which contains
only the protein components, it is involved in the early phase
of the box C/D snoRNP biogenesis. The mammalian RUVBL1
and RUVBL2 bind box C/D snoRNAs and all components of the
R2TP complex are essential for their assembly (Newman et al.,
2000; Boulon et al., 2008). Similarly to yeast Pih1, human PIH1D1
binds NOP58 and a snoRNP assembly factor NUFIP. A recent
proteomic analysis revealed that RUVBL1 and RUVBL2 are com-
ponents of various maturation stages of human pre-snoRNPs and
are released at the ﬁnal stage of snoRNPmaturation. In accordance
with the data from yeast experiments, PIH1D1 and RPAP3 were
not detected in any stage of pre-snoRNPs, which raises the pos-
sibility that PIH1D1 and RPAP3 may in ATP dependent manner
load RUVBL1/2 to the ﬁrst RNA-free stage of snoRNP formation
and do not take part in the latter stages of the assembly (Bizarro
et al., 2014).
At least two assembly factors – Shq1 and Naf1 – are important
for biogenesis of yeast H/ACA snoRNPs (Machado-Pinilla et al.,
2012). Shq1 binds a component of the H/ACA snoRNP complex
Nap57 and prevents the binding of Naf1 to the other snoRNP
components (Yang et al., 2002; Grozdanov et al., 2009). Accord-
ingly, the release of human SHQ1 from NAP57 is required for
H/ACA snoRNP assembly. Cytosolic extracts from Hela cells were
able to remove SHQ1 from NAP57 in an ATP independent man-
ner and SHQ1 removal was inhibited by addition of antibodies
directed at the R2TP component, but not by addition of HSP90
inhibitors. NAP57 directly binds PIH1D1 in vitro and interaction
of its unstructured C-terminal part with RUVBL1/2 was essential
for its disassociation from SHQ1. These experiments indicate that
the R2TP complex takes action at the early stage of the H/ACA
snoRNP assembly and is required for removal of inhibitors of
H/ACA snoRNPs assembly from the H/ACA snoRNPs precursors.
NAP57 lacks the DpSDD PIH-N domain consensus binding-
motif, however, it contains phosphorylated acidic sequences that
may mediate the interaction with the PIH-N domain. Since
the puriﬁed R2TP complex was unable to release NAP57 from
SHQ1, additional factors may be required for this reaction or
for proper assembly of the R2TP complex itself (Machado-Pinilla
et al., 2012).
ASSEMBLY OF RNA POLYMERASE II
Eukaryotic cells contain three different RNA polymerases:
(a) RNA polymerase I produces ribosomal RNA, (b) RNA
polymerase II transcribes small nuclear RNAs and messen-
ger RNAs, and (c) RNA polymerase III produces a range
of small RNAs including the transfer RNAs. RNA poly-
merase II consists of 12 subunits of which Rpb1 and Rpb2
form the active cleft, while the other subunits are located
further in the periphery of the complex (Cramer et al.,
2008).
The R2TP complex together with the prefoldin-like complex
interacts with RNA polymerase II and is involved in its assembly
in the cytoplasm and in the transport of the assembled poly-
merase to the nucleus. Quantitative mass spectrometry analysis
revealed that the polymerase is assembled in several steps, which
include formation of two RNA polymerase II sub-complexes. The
R2TP complex preferentially interacts with unassembled RPB1
and with the sub-complex containing RPB1. Depletion of RPAP3
and inhibition of HSP90 led to destabilization of RPB1 in the
cytoplasm. Interestingly, RPAP3 also binds to RNA polymerase
II subunit RPB5 independently on RPB1 and is required for its
incorporation within the RNA polymerase II complex. RPB5
binds to the component of the human prefoldin-like complex
URI, also involved in the assembly of RNA polymerases in the
cytoplasm (Miron-Garcia et al., 2013). Thus, the prefoldin-like
complex may be also involved in RPB5 assembly in the RNA poly-
merase II complex. It is highly possible that RPB1 is recruited
to the R2TP complex via direct or indirect phosphorylation-
dependent interaction with the PIH-N domain, because wild
type but not mutated PIH-N domain binds phosphorylated RPB1
(Horejsi et al., 2014). RPB1 does not contain the DSDD motif,
recognized by the PIH-N domain, but it contains other phos-
phorylated acidic Casein Kinse 2 (CK2) consensus sequences,
which could bind to PIH-N. Alternatively, the interaction may
be mediated by another factor binding to the PIH-N domain and
to RPB1.
RNA polymerase I and III are also multi-subunit complexes.
Since R2TP complex interacts with several of their subunits, it
is highly possible that the R2TP complex is also involved in their
assembly (Jeronimo et al., 2004, 2007; Boulon et al., 2012). In addi-
tion, PIH1D1 is directly involved in mTORC1-dependent rRNA
transcription by RNA polymerase I (Zhai et al., 2012).
ASSEMBLY OF PHOSPHATIDYLINOSITOL 3-KINASE-RELATED
KINASES
The PIKK family consists of ATM, ATR, DNA-PKcs, mTOR,
SMG1, and TRRAP. ATM, ATR, and DNA-PKcs are essential
for DNA damage signaling (Zhou and Elledge, 2000; McKin-
non, 2012); SMG1 regulates nonsense-mediated mRNA decay
by the mRNA surveillance complex that removes mRNAs with
premature stop codons (Yamashita et al., 2005); TRRAP is part
of multiple acetyltransferase complexes and facilitates transcrip-
tion by binding transcription factors like E2F and c-MYC (Grant
et al., 1998; McMahon et al., 1998, 2000; Murr et al., 2007); and
mTOR is a central player in cellmetabolismand regulates processes
like cell growth, autophagy, transcription, and actin organization
in reaction to growth factor signaling and nutrient availability
(Wullschleger et al., 2006). All PIKKs bind toHSP90 co-chaperone
TEL2, which forms together with its interacting partners TTI1
and TTI2 so called TTT complex. TEL2 phosphorylated on ser-
ine 487 and 491 by CK2 binds to the PIH-N domain present in
PIH1D1 andmutation of both serines disrupts its interaction with
R2TP complex, but does not affect the binding of PIKKs and
HSP90 (Horejsi et al., 2010). Therefore the TTT complex con-
nects PIKKs to both HSP90 and R2TP complex independently
of each other. Knock-out of TEL2 and knock-down of TTI1 ad
TTI2 lead to depletion of PIKKs from cells (Horejsi et al., 2010;
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Hurov et al., 2010). Interestingly, HSP90 inhibition decreases lev-
els of ATM and DNA-PKcs but does not affect levels of mTOR
and SMG1 (Takai et al., 2007), while disruption of TEL2-R2TP
binding affects stability of SMG1 andmTOR (Horejsi et al., 2010),
but also of ATM and DNA-PKcs (Rao et al., 2014). At the same
time depletion of RUVBL1 and RUVBL2 leads to decreased PIKKs
levels (possibly by affecting both transcription of genes encod-
ing RUVBL1/2 and protein stability) and reduces PIKK signaling
(Izumi et al., 2012). It is therefore possible that HSP90 alone is
important for proper folding of ATM and DNA-PKcs, while in
complex with R2TP it mainly affects assembly of complexes of
all PIKKs. As many subunits of large complexes become unsta-
ble if the complex formation is disrupted, it is possible that the
instability caused by non-functional TEL2 or R2TP complex is
not due to improper folding of the kinases themselves, but due
to disruption of complexes in which they are involved. This
is also supported by the fact that reduced levels of RUVBL1/2
impair formation of the mRNA surveillance complex, which con-
tains SMG1 and mTORC1 complex (Izumi et al., 2010; Kim et al.,
2013).
mTOR forms two distinct complexes: (a) mTORC1 is associ-
ated with Raptor and regulates protein synthesis, (b) mTORC2 is
associated with Rictor and is involved in actin organization (Kim
et al., 2002; Sarbassov et al., 2004). Study inmouse andhuman cells
showed that knockdown of TEL2, TTI1, and RUVBL1/2 mediated
by siRNA reduced mTOR activity several folds and led to disrup-
tion of mTOR dimer and impediment of the mTORC1 assembly
(Kim et al., 2002; Sarbassov et al., 2004; Hoffman et al., 2010).
The interaction between TEL2 and mTOR was dependent on the
ATPase activity of RUVBL1 and RUVBL2 and was destabilized in
the absence of ATP or glucose and glutamine starvation condi-
tions (Kim et al., 2013). At the same time, destabilization of TEL2
and mTOR interaction led to decreased mTOR levels. Interest-
ingly, low levels of glucose and glutamine led to decreased stability
of other PIKKs as well, suggesting that nutrient signaling regu-
lates also other cellular pathways by affecting the R2TP complex
stability. The study in human and mouse cells focused only on
members of the TTT complex and RUVBL1/2, but since TEL2
interacts with RUVBL1/2 through direct interactionwith PIH1D1,
the assembly of mTORC1 is regulated by CK2 (Fernandez-Saiz
et al., 2013) and PIH1D1 directly binds to mTORC1, it is highly
probable that the whole R2TP complex takes part in the mTORC1
assembly. This is also supported by the fact that the R2TP complex
is involved in mTORC1 regulated rRNA transcription (Zhai et al.,
2012).
ATR is activated in response to presence of single-stranded
DNA, which is generated during repair of wide variety of DNA
damage lesions and during replication stress. Upon activa-
tion, ATR forms a heterodimer with ATRIP and is recruited
to the single-stranded DNA, coated by replication protein A
(Nam and Cortez, 2011). Knock-down of TEL2 by siRNA
ﬁrstly leads to decreased ATR activation and inhibits binding
of the ATR/ATRIP heterodimer to DNA damage mediator pro-
tein TOPBP1 and later it leads to decreased levels of ATR and
ATRIP (Rendtlew Danielsen et al., 2009). It is therefore possi-
ble that TEL2 interaction with the R2TP complex is required
for formation of the ATR/ATRIP/TOPBP1 complex and that
ATR and ATRIP become unstable if they cannot form the active
complex.
MOLECULAR MECHANISM OF R2TP FUNCTION AND ITS
REGULATION
Although the work on snoRNPs assembly provides some clues
about the mechanism of the R2TP complex function, most of
it is still largely unknown. It seems that in mammals, PIH1D1
and RPAP3 are required at the early stages of complex forma-
tion, probably for loading of RUVBL1/2 to the assembled complex
(Bizarro et al., 2014). RUVBL1/2 are required either to disassem-
ble inhibitors of complex formation or are involved in some other
steps of assembly and/or activation of the late stages of the assem-
bled complexes (Nano and Houry, 2013). Given that RUVBL1/2
are known to be parts of many diverse cellular complexes, it is
intriguing to hypothesize that the R2TP complex is involved in
assembly of all these complexes.
The work on assembly of mTORC1 complex revealed that
assembly of the R2TP complex itself is regulated by presence of
nutrients and the complex becomes disassembled particularly in
the absence of glucose and glutamine. The absence or presence
of glucose and glutamine also regulates localization of the R2TP
complex: in growing yeasts, the R2TP complex is localized in the
nucleus and interacts with box C/D snoRNPs, while it relocalizes
to the cytoplasm in poorly growing cells (Kakihara et al., 2014).
These results show that nutrient signaling affects (via regulation
of R2TP complex assembly and localization) various processes
in the cells. Although the R2TP complex is also involved in reg-
ulation of DNA damage response, it is not known whether the
DNAdamage signaling affects localizationor assembly of theR2TP
complex.
R2TP COMPLEX AND THE DNA DAMAGE RESPONSE
In order to protect genome integrity, cells are equipped with an
extensive response mechanism that comes into play after DNA
damage. Proper function of the DNA damage response pathways
is essential for cancer avoidance (Bartkova et al., 2005).
The general mechanism of the DNA damage response consists
of sensors, transducers, and effectors. The sensors detect the dam-
aged DNA and activate PIKKs ATM, ATR and DNA-PKcs, which
transmit the signal to effector proteins (Zhou and Elledge, 2000).
Depending on the amount of the damage, the effector proteins
(including transcription factor p53) arrest the cell cycle by acti-
vating the checkpoints and either repair the damaged DNA or (in
case of too extensive damage) activate pathways leading to cellular
senescence or apoptosis (Banin et al., 1998; Canman et al., 1998;
Zhou and Elledge, 2000; Vousden and Lu, 2002).
The R2TP complex regulates the DNA damage response by
affecting stability of all PIKKs involved in the DNA damage
response and by regulation of ATR activity. In addition, muta-
tion of the phospho-binding domain PIH-N caused decreased
p53 activation following induction of DNA double strand breaks
even in the presence of normal levels of ATM and DNA-PKcs, the
two PIKKs responding to this type of DNA damage, suggesting
that the R2TP complex regulates activity of ATM and DNA-PKcs
or of other components of the DNA damage pathways (Horejsi
et al., 2010). One of such components might be ECD, a protein
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that directly interacts with p53 and promotes its stabilization by
inhibiting its binding to MDM2 (Zhang et al., 2006). ECD con-
tains two DSDD motifs, which are both required for its direct
phosphorylation-dependent interaction with the R2TP complex.
Hypothetically, theR2TP complexmay either guide the interaction
between ECD and p53 ormay be involved in theMDM2 disassoci-
ation from p53. The latter possibility is supported by the fact that
HSP90 directly interacts with p53 and regulates its stability (Sasaki
et al., 2007).
Another PIH1D1 phospho-binding partner involved in DNA
damage is an E3 ubiquitin ligase UBR5, which regulates trans-
duction of the DNA damage signaling to the effectors (Zhou
and Elledge, 2000; Gudjonsson et al., 2012). The decreased p53
activity in the presence of mutated PIH1D1 could be due to dis-
ruption of the interaction between UBR5 and PIH1D1, although
the mechanism is unclear.
The chromatin remodeling complexes TIP60, INO80, and
SWI/SCRAP that contain RUVBL1/2 have been all implicated in
regulation transcription, replication, recombination, and repair
of DNA damage (Murr et al., 2006). The TIP60 complex possesses
an acetyl-transferase activity, which is essential for accumulation
of repair proteins at the site of the damaged DNA, activation of
ATM (100) and removal of H2AX from the chromatin (Sun et al.,
2005; Ikura et al., 2007). In addition, acetylation of p53 by TIP60
directs thep53 response toward inductionof apoptosis. RUVBL1/2
are required for acetylation of at least some of the TIP60 targets
(Ikura et al., 2007; Jha and Dutta, 2009).
INO80 is involved in repair of DNA double strand breaks by
sliding nucleosomes along the DNA and their eviction at the site
of the damage. Yeast Rvb1/2 bind to Ino80 subunit Arp5 in anATP
but not ATPase dependent manner and their loss leads to disas-
sociation of Arp5 from the complex and to the loss of chromatin
remodeling activity of the complex (Shen et al., 2003; Osakabe
et al., 2014).
The yeast SWI complex, known as SRCAP complex in mam-
malian cells, remodels chromatin by catalyzing replacement of
histone dimers H2A-H2B in nucleosomes by dimers containing
the histone variant Htz1 in yeast or H2AZ in mammals. This
Table 2 | Confirmed and potential targets of the R2TP complex.
Function Direct interaction
R2TP complex target Target complex R2TP complex R2TP
component
Target complex
component
Confirmed
RNA polymerase II Transcription Assembly ? ?
snoRNPs Biogenesis of ribosomes,
spliceosomes, and telomerase
boxC/D snoRNPs 2′-O-methylation of preRNA Assembly PIH1D1? NOP58?
H/ACA snoRNPs Pseudouridylation of prerRNA Assembly PIH1D1? NAP57?
SMG1 Nonsense mediated mRNA decay Assembly PIH1D1 TEL2
mTORC1 Central regulator of cell metabolism Assembly PIH1D1 TEL2
ATM/ATR/DNA-PK Kinases involved in DNA damage
signaling
Possibly assembly PIH1D1 TEL2
Potential
ECD/p53 Transcription factor involved in DNA
damage response
possibly assembly PIH1D1 ECD
UBR5 E3 ubiquitin ligase involved in DNA
damage signaling
? PIH1D1 UBR5
INO80 Chromatin remodeling complex,
involved in repair of DNA double
strand breaks
Possibly loading RUVBL1/2 ? ?, RUVBL1/2
TIP 60 Chromatin remodeling complex,
acetyl-transferase activity important
for DNA damage response
Possibly loading RUVBL1/2 ? ?, RUVBL1/2
SWI/SCRAP Chromatin remodeling complex,
DNA damage signaling
Possibly loading RUVBL1/2 ? ?, RUVBL1/2
Fanconi anemia core complex Recognition and repair of DNA
crosslinks
Possibly loading RUVBL1/2 ? ?, RUVBL1/2
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process is essential for DNA damage signaling, although the role
of RUVBL1/2 in it is not known (Niimi et al., 2012).
Very recently, it has been reported that RUVBL1/2 are asso-
ciated with Fanconi anemia core complex. This complex is
essential for recognition and repair of DNA cross-links. Knock-
down of RUVBL1/2 shows similar phenotype as depletion of the
Fanconi anemia core complex proteins and conditionally knock-
out cells depleted from RUVBL1/2 have highly reduced levels
of the Fanconi anemia core complex proteins (Rajendra et al.,
2014).
The role of RUVBL1/2 in all the mentioned complexes is
unknown, but in light of the recent ﬁndings about snoRNPs assem-
bly and about the essential role of RUVBL1/2 in incorporation of
Arp5 into the Ino80 complex, it is highly probable that RUVBL1/2
are necessary for assembly and activation of these complexes. It
would be extremely interesting to know whether PIH1D1 and
RPAP3 are involved in the early stages of their assembly by loading
RUVBL1/2 onto these complexes.
R2TP COMPLEX IN CANCER
Components of the R2TP complex are over-expressed in can-
cer: PIH1D1 levels are increased in several breast cancer cell lines
(Kamano et al., 2013), RUVBL1/2 are over-expressed in liver and
colon cancers (Huber et al., 2008; Jha and Dutta, 2009; Grigoletto
et al., 2011) and their higher expression in cancer tissues is posi-
tively correlatedwith the expression of genes involved inmetabolic
processes activated by mTOR signaling (Kim et al., 2013). HSP90
levels are high in various cancer cell lines (Calderwood et al., 2006)
and its activity is essential for variety of processes in cancer cells.
It also plays a key role in the conformational maturation of onco-
genic signaling proteins such as HER-2/Erb2, Akt, Raf-1, Bcr-Abl,
and mutated p53. Multiple drugs that inﬂuence the substrates of
R2TP or HSP90 chaperone are currently used or tested for the
treatment of cancer. HSP90 became an attractive antineoplastic
drug target, currently with 17 agents in different stages of clini-
cal trials (Neckers and Workman, 2012) and inhibition of HSP90
reveals signiﬁcant treatment effects in vitro in different types of
cancers of unmetneed such as the glioblastoma, lung, andpancreas
cancer (Mayer et al., 2012; Choi et al., 2014; Pillai and Rama-
lingam, 2014; Wachsberger et al., 2014). Inhibition or depletion
of HSP90 co-chaperones such as p23, Cdc37, and Aha1 further
sensitizes cells to HSP90-targeted drugs (Neckers and Workman,
2012). Increased mTOR activity can promote tumor growth and
mTOR inhibitors are already used in the clinic (Fruman and Rom-
mel, 2014). CK2 is essential for cellular viability and progression
of the cell cycle. It is required for tumorigenesis, but the exact
mechanism is not clear (Trembley et al., 2010). Sites phosphory-
lated by CK2 form protein–protein interaction motifs, critical for
regulation of DNA damage response pathways (Iles et al., 2007;
Chapman and Jackson, 2008; Horejsi et al., 2010; Yata et al., 2012;
Guerra et al., 2014; Horejsi et al., 2014) and for recognition of
speciﬁc substrate by the R2TP complex. The relevance of CK2 as
a molecular target in cancer has led to the development of CK2
inhibitors for clinical use, which are potent, highly speciﬁc and
FIGURE 3 | Assembly of multiple-subunit complexes by R2TP. The
multiple-subunit complexes in mammalian cells are assembled in several
steps: the early phase requires presence of R2TP complex, which may serve
to remove assembly inhibitors (I) and/or to load RUVBL1/2 to the premature
complexes in ATP dependent manner. RUVBL1/2 helps in the latter stage of
assembly forming the mature complexes and either disassociate from or
become part of the mature complexes. The substrate (X, Y) speciﬁcity is given
by presence of phosphorylated sequence (P), recognized by PIH-N domain
and possibly by speciﬁc interactions with other components of the R2TP
complex.
Frontiers in Genetics | Cancer Genetics February 2015 | Volume 6 | Article 69 | 8
von Morgen et al. R2TP complex in stress response and cancer
orally available, with known antitumor efﬁcacy in breast, pan-
creatic and prostate xenograft mouse models (Cozza et al., 2013;
Gyenis et al., 2013).
The R2TP complex speciﬁcally recognizes sites phosphorylated
by CK2 and works in conjunction with HSP90 to assemble multi-
subunit complexes involved in many cellular processes highly
relevant to cancer, which makes it a promising target for new
cancer drugs. Potential targets include the ATPase activity of
RUVBL1 or RUVBL2 (Elkaim et al., 2012; Grigoletto et al., 2013)
and PIH-N domain binding – inhibitors that block the PIH-N
phospho-binding bymimicking the DpSDDmotif should prevent
function of the R2TP. The R2TP complex inhibitors could be of
value in a clinical setting either to enhance HSP90, CK2, ATM
and ATR inhibitors, to sensitize cells to cancer treatment based
on induction of DNA damage (radiotherapy and some types of
chemotherapy) or as an alternative to HSP90 inhibitors.
FUTURE DIRECTIONS
The R2TP complex is implicated in the assembly of multiple
cellular complexes (Table 2). The mechanisms by which the
R2TP complex recognizes its substrates and exerts its function are
still not completely understood. Strikingly, the experiments with
snoRNPs assembly indicate that disruption of protein interactions
and loading of RUVBL1/2 onto the premature complexes may be
a general R2TP function (Figure 3). Indeed, NOP56 and NOP58,
components of boxC/D snoRNPs, have homology to the unstruc-
tured tail of H/ACA snoRNP component NAP57, important for
NAP57 disassociation from SHQ1 (Machado-Pinilla et al., 2012).
The identiﬁcation of the PIH-N domain helps us to understand
the principle of recognition of R2TP substrate and could assist
in the search for novel R2TP complex substrates. As the interac-
tion between PIH-N and its substrate is phosphorylation-speciﬁc
and the main kinase involved in the substrate phosphorylation
seems to be CK2 (Horejsi et al., 2010, 2014), better understanding
of its activation in response to different stimuli and/or identiﬁ-
cation of other kinases phosphorylating the substrate will lead
to better understanding of regulation of R2TP function. Indeed,
although CK2 has been regarded as a constitutive kinase not sub-
ject to regulation, recently published data show that binding of
5-diphosphoinositol pentakisphosphate (IP7) to CK2 enhances
its phosphorylation of TEL2 and increases stability of DNA-PKcs
and ATM after DNA damage (Rao et al., 2014).
One of the main functions of the R2TP complex could be
regulation of cellular energy balance. The assembly of RNA poly-
merase II, mTORC1, ribosomes and spliceosomes (through the
snoRNPS) is dependent on the R2TP complex. The presence of
ATP increases the presence of higher order RUVBL complexes
(McKeegan et al., 2009) and stimulates R2TP mediated assembly
of mTOR and rRNA transcription (Kim et al., 2013). Therefore
R2TP may work as a metabolic switch or master regulator by
simultaneous inﬂuencing mTOR activity, protein synthesis and
other cellular processes such as transcription and response toDNA
damage.
Most of R2TPs functionalmechanisms still remain elusive: how
does R2TP assert its function on its substrates? What is the role
of the prefoldin/like complexes associated with the R2TP com-
plex? Are the differences in the structures reported for the RUVBL
hexameres relevant for its function? What is the role of HSP90
in the R2TP complex? Is the PIH-N domain always involved in
R2TP substrate recognition? Is PIH-N domain involved in regu-
lating assembly processes? Is the R2TP complex generally involved
in assembly of complexes containing RUVBL1/2? Answering these
questions will allow us to start understanding of the molecular
mechanisms of the function of this highly important complex.
Also,more studies are required to evaluate the attractive possibility
that the R2TP inhibitors are relevant in cancer treatment.
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